Apellis Pharmaceuticals (APLS) Stock Price Today & Analysis

APLS
APLS company logo
Loading...
Chart by TradingView

Valuation

Market cap$2.52B
Price-to-sales ratio2.56
Price-to-book value6.48
Price-earnings ratio57.70
Return on Equity19.00%
Return on Sales0.09%
Return on Assets0.05%
PEG ratioN/A

Earnings Per Share

Earnings Per Share$0.35

Income Statement

Average volume2,833,177
EBITDA$93.37M
1 year high (52w)$31.17
1 year low (52w)$16.10

Dividend

Dividend yield0.00%

Solvency

Debt-to-equity ratioN/A

About Apellis Pharmaceuticals

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. It offers EMPAVELI for the treatment of paroxysmal nocturnal hemoglobinuria, cold agglutinin disease, C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis, amyotrophic lateral sclerosis, and hematopoietic stem cell transplantation-associated thrombotic microangiopathy; and SYFOVRE for treating geographic atrophy (GA). The company has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) for development and commercialization of pegcetacoplan; and a collaboration with Beam Therapeutics Inc. focused on the use of Beam's base editing technology to discover new treatments for complement-driven diseases. The company was incorporated in 2009 and is based in Waltham, Massachusetts.

FAQ

You can easily purchase Apellis Pharmaceuticals (APLS) shares through the Gotrade app. Simply download the app, set up your account, fund it, and then search for the 'APLS' ticker to begin your investment journey.
At Gotrade, you can kickstart your investment in Apellis Pharmaceuticals with as little as $1.
Absolutely. Brokerage services on Gotrade Indonesia are provided by PT Valbury Asia Futures, a licensed futures and commodities broker registered with and supervised by the Indonesian Financial Services Authority (OJK).
Yes. Gotrade provides access to U.S. stocks from Indonesia through fully backed shares. This is facilitated through a cross-border order routing scheme for foreign stock derivative contracts (PALN), in accordance with regulations from Bappebti (the Commodity Futures Trading Regulatory Agency).
When you trade, you enter into a contract with PT Valbury Asia Futures (Valbury), a Bappebti-registered broker in Indonesia. Valbury, in turn, fully backs its contracts 1-for-1 with Alpaca Securities LLC, a FINRA-licensed broker-dealer in the United States. For every share (or fraction thereof) you hold on Gotrade, a corresponding share is held by Valbury in a separate, segregated brokerage account at Alpaca Securities LLC.
AppLogo

Buy saham APLS
di Gotrade

AppLogo

Gotrade